Freie Mitteilungen

Functional modification of the CXCR4 chemokine receptor in leukemic cells by targeting phosphorylation of its intracellular tail

S. Thommen¹, L. Brault¹, S. Ehret¹, J. Schwaller¹ (¹Basel)

Repression of microRNA-29, -143 and -145 contributes to the pathogenesis of acute promyelocytic leukemia

J. Batliner¹, E. Buehrer¹, A. Tobler¹, M. F. Fey¹, M. P. Tschan¹ (¹Bern)

Deregulated expression of Krüppel-like factors in acute myeloid leukemia

M. Humbert¹, V. Halter¹, A. Tobler¹, M. F. Fey¹, M. P. Tschan¹ (¹Bern)

Induction of immunogenic cell death through ecto-calreticulin exposure following anthracycline treatment in acute myeloid leukemia (AML)

S. Mans¹, M. Eyholzer¹, D. Shan¹, M. Legros¹, B. U. Müller¹, T. Pabst¹ (¹Bern)

An inhibitor of NAD synthesis specifically kills hematopoietic tumoral cells

A. Nahimana¹, A. Attinger¹, D. Aubry¹, P. Greaney¹, C. Ireson¹, A. V. Thougaard², J. Tjørnelund², K. M. Dawson¹, M. Dupuis¹, M. A. Lausanne¹ (¹Lausanne; ²Copenhagen DK)

Role of Growth arrest-specific gene 6 (Gas6) in iron metabolism

L. Kadi¹, A. Brisset¹, F. Saller¹, B. Ternon¹, M. Azevedo¹, A. Angelillo-Scherrer¹ (¹Lausanne)

Unexpected role for connexin37 in circulating FVIII and coagulation

L. Burnier¹, A. Pfenniger², S. Taffet³, M. Delmar⁴, P. Fontana², B. R. Kwak², A. Angelillo-Scherrer⁵ (¹Genève & Lausanne; ²Genève; ³Syracuse USA; ⁴Ann Arbor USA; ⁵Lausanne)

Dietary alpha-linolenic acid (ALA) increases 3-series isoprostanes and diminishes atherogenesis by restricting T cell-driven inflammation

S. Winnik¹, C. Matter¹, C. Lohmann¹, E. Richter¹, N. Schäfer¹, W. L. Song², F. Leiber¹, R. Klingenberg¹, J. Borén³, G. A. Fitzgerald², T. F. Lüscher¹, J. H. Beer⁴ (¹Zürich; ²Philadelphia; ³Goteborg; ⁴Baden)

Extensive L-tryptophan catabolism induced by gamma-IFN activated human mesenchymal stem cells is essential for the establishment of their inhibition on T lymphocytes

V. Kindler¹, N. Brouwers¹, M. Barnet¹, J. Passweg¹, J. Villard¹, A. Pradier¹ (¹Genève)

Effects of a simple guideline for transfusion of red blood cells (RBC) in elective hip and knee replacement on blood supply and costs

S. Fontana¹, U. Müller¹, M. Perler¹, L. Krummen¹, A. Lädrach¹, C. De La Cuadra¹, M. Luginbühl¹, B. Mansouri Taleghani¹ (¹Bern)

Anti-HLA/HPA-Antibodies in Female Blood Donors depend on Gravidity Status and remain live-long

B. M. Frey¹, B. Grossrieder¹, A. Nikos¹, P. Lodemann¹ (¹Schlieren)

Key aspects in the management of acute haemarthrosis in haemophilia: An European survey

P. De Moerloose¹, M. Richards², K. Fischer³, R. Klamroth⁴, T. Lambert⁵, R. Perez⁶, G. Dolan⁷, C. Hermans⁸ (¹Genève; ²Angleterre; ³Netherlands; ⁴Germany; ⁵France; ⁶Spain; ⁷United Kingdom; ⁸Belgique)

Survival and relapse in patients with thrombotic thrombocytopenic purpura

J. A. Kremer Hovinga¹, S. K. Vesely², D. R. Terrell², B. Lämmle¹, J. N. George² (¹Bern; ²Oklahoma USA)

Rapid Exclusion or Confirmation of Heparin-induced Thrombocytopenia: A Single-Centre Experience with 1291 Patients

L. A. Alberio¹, V. Nellen¹, I. Sulzer¹, G. Barizzi¹, B. Lämmle¹ (¹Bern)

Antiphospholipid antibodies stimulate human endothelial cells and monocytes via TLR2

P. De Moerloose¹, E. Kruithof¹, C. Fickentscher¹, D. Burger¹, G. Reber¹, N. Satta¹ (¹Genève)

The Effect of Desmopressin (DDAVP) on Platelet Function: Selective and Marked Enhancement of Platelet Procoagulant Activity

L. A. Alberio¹, M. Pavicic¹, G. Colucci¹, M. Reusser¹, T. Conte¹, M. Stutz¹, C. Thürlemann¹, P. Keller¹ (¹Bern)

HLA-DP is an alloantigen in unrelated hematopoietic stem cell transplantation

J. M. Tiercy¹, F. Bettens¹, A. Gratwohl², U. Schanz³, T. Gungor³, Y. Chalandon¹, D. Heim², G. Stüssi³, G. Nicoloso⁴, H. Baldomero², J. Passweg¹ (¹Genève; ²Basel; ³Zürich; ⁴Bern)

Allogeneic HSCT for Lymphoid Neoplasia, a report by the Swiss Blood and Marrow Stem Cell Transplant Group (SBST)

J. Passweg¹, H. Baldomero², M. Stern², C. Bucher², A. Buser², Y. Chalandon¹, D. Heim², B. Mohty¹, M. Nagy-Hulliger¹, G. Stüssi³, U. Schanz³, A. Gratwohl² (¹Genève; ²Basel; ³Zürich)

Cyclosporine Levels and Rate of Graft Rejection Following Reduced Intensity Conditioning

S. Gerull¹, A. Buser¹, C. Arber¹, C. Bucher¹, D. Heim¹, J. Halter¹, A. Gratwohl¹, A. Tichelli¹, M. Stern¹ (¹Basel)

Skewed T cell Receptor Repertoires in very long term survivors after allogeneic hematopoietic stem cell transplants

A. Rovo¹, C. Arber¹, P. Fisch², U. Siegler¹, G. M. Baerlocher³, T. Daikeler¹, J. Halter¹, M. Stern¹, D. Heim¹, A. Tyndall¹, A. Gratwohl¹, A. Tichelli¹ (¹Basel; ²Freiburg; ³Bern)

Large granular lymphocyte expansion following allogeneic hematopoietic stem cell transplantation

S. Nann-Rütti¹, A. Tzankov², J. Halter², D. Heim², D. A. Tsakiris², C. Arber², A. Buser², A. Gratwohl², A. Tichelli², A. Rovo² (¹Münchenstein; ²Basel)

Eine doppelblind randomisierte Studie zu Denosumab im Vergleich zu Zoledronsäure für die Behandlung von Knochenmetastasen bei Patienten mit fortgeschrittenen Tumorerkrankungen (Mamma- und Prostatakarzinom ausgeschlossen) oder multiplem Myelom

R. Von Moos¹, D. Henry², S. Vadhan-Raj³, V. Hungria⁴, A. Spencer⁵, V. Hirsh⁶, J. Wang⁷, S. Jun⁷, R. Dansey⁷, H. Yeh⁷ (¹Chur; ²Philadelphia; ³Houston; ⁴Sao Paulo; ⁵Melbourne; ⁶Montreal; ⁷Thousand Oaks)

Molecular Monitoring of CML Therapy in Switzerland – Standardization of BCR-ABL Real-time PCR Quantification

E. Oppliger Leibundgut¹, B. Hügli¹, N. A. Porret¹, J. Goede², C. Arber³, M. Hergersberg⁴, W. Korte⁵, R. Darbellay⁶, C. Abbal⁷, G. M. Baerlocher¹ (¹Bern; ²Zürich; ³Basel; ⁴Aarau; ⁵St. Gallen; ⁶Genève; ⁷Lausanne)

Monoclonality testing using pyrosequencing

T. Matthes¹, D. Robert¹, P. Makrythanasis¹, L. Busque², S. Mach-Pasqual¹, S. Deutsch¹ (¹Genève; ²Montreal CA)

Increased Dkk3 protein expression on platelets and megakaryocytes in patients with myeloproliferative neoplasms

M. Medinger¹, A. Tzankov², J. Kern¹, G. Gastl¹, G. Untergasser¹, E. Gunsilius¹ (¹Innsbruck AT; ²Basel)

Diesel Exhaust Particles Induce Shedding of GPIb alpha, but not of GPVI

M. Forestier¹, M. Al-Tamimi², E. Gardiner², J. H. Beer¹ (¹Baden; ²Melbourne AUS)